GMT EIGHT - Market

Hallgain Management Limited increased its stake in KINGBOARD HLDG(00148) by 150,000 shares at approximately HK$15.25 per share.

According to the latest information from the Hong Kong Stock Exchange, on September 13th, Hallgain Management Limited increased its holdings in KINGBOARD HLDG(00148) by 150,000 shares, at an average price of 15.2533 Hong Kong dollars per share, with a total amount of approximately 2.288 million Hong Kong dollars. After the increase, the latest number of shares held is approximately 476 million shares, with a latest holding percentage of 42.95%.

16/09/2024

Chairman Zhang Guorong increased his holding of KINGBOARD HLDG (00148) by 47,000 shares at an average price of approximately HK$15.18 per share.

According to the latest information from the Hong Kong Stock Exchange, on September 13, Chairman Zhang Guorong increased his holdings of KINGBOARD HLDG (00148) by 47,000 shares, with an average price of HK$15.1821 per share, totaling approximately HK$713,600. After the increase, his latest shareholding is approximately 13.1169 million shares, representing a stake of 1.18%.

16/09/2024

Non-executive director Chen Jiarong reduces his holding of 6,489,500 shares of MEITU (01357) at a price of approximately HK$2.13 per share.

According to the latest information from the Hong Kong Stock Exchange, on September 13th, non-executive director Chan Kar Wing reduced his holdings of MEITU (01357) by 6.4895 million shares, with an average price of 2.134 Hong Kong dollars per share, totaling approximately 13.8486 million Hong Kong dollars. After the reduction, the latest number of shares held is 0.

16/09/2024

Norway's central bank increased its holdings in Asymchem Laboratories (06821) by 13,090 shares at a price of approximately 38.85 Hong Kong dollars per share.

According to the latest data from the Hong Kong Stock Exchange, on September 10, the Central Bank of Norway increased its holdings of Asymchem Laboratories (06821) by 130,900 shares, with an average price per share of HK$38.8452, for a total amount of approximately HK$5.0848 million. After the increase, the latest number of shares held is 1,697,100 shares, and the latest shareholding ratio is 6.16%.

16/09/2024

Weike (Hong Kong) Economic and Trade increased its stake in Pieeau (02315) by 700,000 shares at a price of HK$5.85 per share.

According to the latest data from the Hong Kong Stock Exchange, on September 11th, Vico (Hong Kong) Trade and Commerce Co., Ltd. increased their holdings of Bausch Health Companies Inc. (02315) by 700,000 shares, with an average price of 5.85 Hong Kong dollars per share, for a total amount of 4.095 million Hong Kong dollars. After the increase, the new total holdings are 7,102,580 shares, with a new holding percentage of 6.41%.

16/09/2024

The Pacific increased its holdings in HUADIAN POWER (01071) by 350,000 shares at a price of approximately HK$3.64 per share.

According to the latest information from the Hong Kong Stock Exchange, on September 12th, The Pacific increased its holdings of HUADIAN POWER (01071) by 350,000 shares, with an average price of 3.6414 Hong Kong dollars per share, totaling 1.27449 million Hong Kong dollars. After the increase, the latest number of shares held is approximately 103 million shares, with a new shareholding ratio of 6.01%.

16/09/2024

Chen Yonglu increased his holdings in CN LOGISTICS (02130) by 1,758,000 shares at a price of HK $3.7 per share.

According to the latest information from the Hong Kong Stock Exchange, on September 13, Chan Wing Luk increased his holdings of CN LOGISTICS (02130) by 1,758,000 shares, with an average price of 3.7 Hong Kong dollars per share, totaling 6.5046 million Hong Kong dollars. After the increase, the latest number of holdings is 22,642,000 shares, with a latest holding ratio of 7.53%.

16/09/2024

HK Stock Market Move | SINO-OCEAN GP(03377) reversed its decline and rose more than 16%, with August contractual sales of 20.6 billion RMB, a year-on-year increase of 4.6%.

SINO-OCEAN GP (03377) fell by more than 11% in the morning session, but the stock price turned around and rose nearly 17% in the afternoon. As of the time of writing, it was up 13.25% at HK$0.188, with a turnover of HK$5.2621 million. On the news front, SINO-OCEAN GP announced that its contracted sales in August amounted to RMB 20.6 billion, a year-on-year increase of 4.6%, with a contracted sales area of approximately 178,900 square meters. The average selling price per square meter was RMB 11,500. In the first eight months, the cumulative contracted sales reached RMB 22.18 billion, a year-on-year increase of 44.7%, involving a sales area of approximately 1.8547 million square meters. The average selling price per square meter was RMB 12,000. It is worth noting that SINO-OCEAN GP previously announced that the winding-up petition filed against the company had been adjourned to September 23, 2024, at the Hong Kong High Court hearing on September 11, 2024. On September 10, SINO-OCEAN GP announced the latest debt restructuring progress, with over 75% of holders of the A group debt agreeing to the restructuring support agreement. The company further extended the deadline for the basic agreement fee from September 10 to September 24, stating that some creditors are undergoing internal approval processes and need additional time to complete this process.

16/09/2024

HK Stock Market Move | AKESO(09926) surged over 17% to hit a new high, with a cumulative increase of over 45% for the month. Morgan Stanley said that the Ivosi HARMONi-2 data far exceeded expectations.

AKESO (09926) surged by over 17% during trading, reaching a high of HKD 72.55, setting a new historical high. The stock has accumulated a gain of over 45% within the month. As of the time of writing, it has increased by 16.06%, trading at HKD 71.5 with a turnover of HKD 9.04 billion. On the news front, on September 8th, clinical data for HARMONi-2 was released at the WCLC annual meeting, with AKESO's PD-1xVEGF dual antibody Ivosiren achieving the primary clinical endpoint of PFS in a head-to-head comparison with a PD-L1(+)NSCLC 1L indication. Huafu Securities pointed out that lung cancer is just the beginning of Ivosiren's global clinical development, and the overseas value of Ivosiren is yet to be reassessed. Morgan Stanley released a research report stating that Ivosiren's HARMONi-2 data exceeded expectations, and adjusting the company's revenue model to reflect overseas income contributions, the company's loss forecast for this year was reduced by 30%, next year's loss forecast by 17%, and the profit forecast for 2026 was raised by 13%. JPMorgan Chase pointed out that considering the upward revision of AK112 sales forecasts, the bank correspondingly increased AKESO's sales forecast by over 40%.

16/09/2024

HK Stock Market Move | ChinaSoft International (00354) rose more than 4% at the close of trading, as demand for self-controlled products has been released, potentially driving the company's business to exceed expectations.

Chinese software international (00354) rose more than 4% in the final trading session, rising 3.74% as of press time to HK$3.88, with a turnover of HK$52.3951 million. On the news front, the 9th Huawei Full Connect Conference with the theme of "Win-Win Industry Intelligence" is set to be held in Shanghai from September 19th to 21st. Analysis points out that the acceleration of HarmonyOS ecosystem construction, as well as the continued empowerment of Ascend computing ecosystem, are expected to drive various industries towards autonomy and localization. In addition, CMSC stated that the work of the nation's mapping industry continues to progress, with potential improvements in funding issues. Guotai Junan pointed out that Chinese software international's performance is gradually stabilizing, with continued strengthening of cost control, multiple emerging businesses blossoming, and a market recovery approaching. The bank noted that the company is actively promoting the implementation of autonomous and controllable products and services in all major business areas. With the continued release of autonomous and controllable demand from key industry customers, the company's business is expected to achieve better-than-expected development.

16/09/2024

Contact: contact@gmteight.com